Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE

Standard Dose
EQ 25MG BASE;10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 211925 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE Form and strength TABLET;ORAL - EQ 25MG BASE;10MG Sponsor MICRO LABS Submission history Latest submission status date: 2025-06-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE is listed in Drugs@FDA under application 211925 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE Form and strength TABLET;ORAL - EQ 25MG BASE;10MG Sponsor MICRO LABS Submission history Latest submission status date: 2025-06-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.